neoX Biotech
PrivateLast Round
Series A
Extension
Jul 8, 2021
Total Funding Raised
$40M
Company Overview
neoX Biotech is a biotechnology company that integrates artificial intelligence, biophysics, and high-throughput experimentation to develop macromolecular and multi-specific drugs for immuno-oncology and other therapeutic areas.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
neoX Biotech Comparables
Compare neoX Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Degron Therapeutics | 79% | |
| BigHat Biosciences | 79% | |
| Beyang Therapeutics Co., Ltd. | 78% | |
neoX Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jul 8, 2021 | ||||
| Series A | Feb 9, 2021 | ||||
| Pre Seed | Jul 6, 2020 | ||||
| Accelerator | Dec 1, 2019 | ||||
| Seed | Aug 24, 2018 | ||||
Seed | Jun 1, 2018 |
neoX Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yuanjing Capital | Series A, Series A Extension, Pre Seed |
| MiraclePlus | Series A Extension |
| ZhenFund | Angel, Seed |
| LYFE Capital | Series A Extension |
| Sky9 Capital | Series A Extension, Series A |
| Genesis Capital | Series A Extension |
| Sequoia Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 298% MoM, reaching 1.3K.
- Jul 8, 2021
Led by Genesis Capital and LYFE Capital.
neoX Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about neoX Biotech's valuation, stock price, and market status.